Dr Asma Ahmed Hassan Elshiekh

  • Research Associate (Therapeutic Science Research)

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2020 | 2019 | 2018 | 2015 | 2014
Number of items: 10.

2024

Ahmed Hassan Elshiekh, A. and Tait, S. W.G. (2024) Tumour immunogenicity goes with the (mitochondrial electron) flow. Molecular Oncology, 18(5), pp. 1054-1057. (doi: 10.1002/1878-0261.13627) (PMID:38520041) (PMCID:PMC11077003)

2023

Ahmed, A. et al. (2023) Immune escape of colorectal tumours via local LRH-1/Cyp11b1-mediated synthesis of immunosuppressive glucocorticoids. Molecular Oncology, 17(8), pp. 1545-1566. (doi: 10.1002/1878-0261.13414) (PMID:36861295) (PMCID:PMC10399709)

2022

Koessinger, A. L. et al. (2022) Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics. Cell Death and Differentiation, 29(10), pp. 2089-2104. (doi: 10.1038/s41418-022-01001-3) (PMID:35473984) (PMCID:PMC9525582)

Blaszczak, W., Ahmed Hassan Elshiekh, A. , Leithner, K., Schubert, A., Leech, M., Bonder, C. and Tsagakis, I. (2022) Outlook of women in science: an interview with our authors. Molecular Oncology, 16(5), pp. 1047-1056. (doi: 10.1002/1878-0261.13189) (PMID:35122410) (PMCID:PMC8895441)

2020

Ahmed, A. and Tait, S. W.G. (2020) Targeting immunogenic cell death in cancer. Molecular Oncology, 14(12), pp. 2994-3006. (doi: 10.1002/1878-0261.12851) (PMID:33179413) (PMCID:PMC7718954)

2019

Ahmed, A. , Schwaderer, J., Hantusch, A., Kolho, K.-L. and Brunner, T. (2019) Intestinal glucocorticoid synthesis enzymes in pediatric inflammatory bowel disease patients. Genes and Immunity, 20(7), pp. 566-576. (doi: 10.1038/s41435-019-0056-1) (PMID:30686824)

Ahmed, A. , Schmidt, C. and Brunner, T. (2019) Extra-adrenal glucocorticoid synthesis in the intestinal mucosa: between immune homeostasis and immune escape. Frontiers in Immunology, 10, 1438. (doi: 10.3389/fimmu.2019.01438) (PMID:31316505) (PMCID:PMC6611402)

2018

Ahmed, A. , Reinhold, C., Rösselet, C., Noti, M., Schoonjans, K. and Brunner, T. (2018) Deficiency of the Nuclear Receptor SHP Ameliorates Inflammation and LRH-1-Driven Colonic Tumor Development. 8th International Conference on Tumor Microenvironment, Lisbon, Portugal, 10-14 Jun 2018. S69. (doi: 10.1007/s12307-018-0212-6)

2015

Ahmed, A. , I.B, E., Barka, O. Z., Kerb, R. and Schwab, M. (2015) Pharmacokinetics of Artesunate, Dihydroartemisinin and α-Dihydroartemisininglucuronide following Oral Administration of Artesunate in Sudanese Patients with Uncomplicated Falciparum Malaria and Healthy Volunteers. The 6th Annual Postgraduate Studies and Scientific Research Conference, Khartoum, Sudan, 18-22 Feb 2015.

2014

Geditz, M. C.K., Heinkele, G., Ahmed, A. , Kremsner, P. G., Kerb, R., Schwab, M. and Hofmann, U. (2014) LC-MS/MS method for the simultaneous quantification of artesunate and its metabolites dihydroartemisinin and dihydroartemisinin glucuronide in human plasma. Analytical and Bioanalytical Chemistry, 406(17), pp. 4299-4308. (doi: 10.1007/s00216-014-7820-x) (PMID:24760398)

This list was generated on Thu Nov 21 03:07:33 2024 GMT.
Number of items: 10.

Articles

Ahmed Hassan Elshiekh, A. and Tait, S. W.G. (2024) Tumour immunogenicity goes with the (mitochondrial electron) flow. Molecular Oncology, 18(5), pp. 1054-1057. (doi: 10.1002/1878-0261.13627) (PMID:38520041) (PMCID:PMC11077003)

Ahmed, A. et al. (2023) Immune escape of colorectal tumours via local LRH-1/Cyp11b1-mediated synthesis of immunosuppressive glucocorticoids. Molecular Oncology, 17(8), pp. 1545-1566. (doi: 10.1002/1878-0261.13414) (PMID:36861295) (PMCID:PMC10399709)

Koessinger, A. L. et al. (2022) Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics. Cell Death and Differentiation, 29(10), pp. 2089-2104. (doi: 10.1038/s41418-022-01001-3) (PMID:35473984) (PMCID:PMC9525582)

Blaszczak, W., Ahmed Hassan Elshiekh, A. , Leithner, K., Schubert, A., Leech, M., Bonder, C. and Tsagakis, I. (2022) Outlook of women in science: an interview with our authors. Molecular Oncology, 16(5), pp. 1047-1056. (doi: 10.1002/1878-0261.13189) (PMID:35122410) (PMCID:PMC8895441)

Ahmed, A. and Tait, S. W.G. (2020) Targeting immunogenic cell death in cancer. Molecular Oncology, 14(12), pp. 2994-3006. (doi: 10.1002/1878-0261.12851) (PMID:33179413) (PMCID:PMC7718954)

Ahmed, A. , Schwaderer, J., Hantusch, A., Kolho, K.-L. and Brunner, T. (2019) Intestinal glucocorticoid synthesis enzymes in pediatric inflammatory bowel disease patients. Genes and Immunity, 20(7), pp. 566-576. (doi: 10.1038/s41435-019-0056-1) (PMID:30686824)

Ahmed, A. , Schmidt, C. and Brunner, T. (2019) Extra-adrenal glucocorticoid synthesis in the intestinal mucosa: between immune homeostasis and immune escape. Frontiers in Immunology, 10, 1438. (doi: 10.3389/fimmu.2019.01438) (PMID:31316505) (PMCID:PMC6611402)

Geditz, M. C.K., Heinkele, G., Ahmed, A. , Kremsner, P. G., Kerb, R., Schwab, M. and Hofmann, U. (2014) LC-MS/MS method for the simultaneous quantification of artesunate and its metabolites dihydroartemisinin and dihydroartemisinin glucuronide in human plasma. Analytical and Bioanalytical Chemistry, 406(17), pp. 4299-4308. (doi: 10.1007/s00216-014-7820-x) (PMID:24760398)

Conference or Workshop Item

Ahmed, A. , Reinhold, C., Rösselet, C., Noti, M., Schoonjans, K. and Brunner, T. (2018) Deficiency of the Nuclear Receptor SHP Ameliorates Inflammation and LRH-1-Driven Colonic Tumor Development. 8th International Conference on Tumor Microenvironment, Lisbon, Portugal, 10-14 Jun 2018. S69. (doi: 10.1007/s12307-018-0212-6)

Ahmed, A. , I.B, E., Barka, O. Z., Kerb, R. and Schwab, M. (2015) Pharmacokinetics of Artesunate, Dihydroartemisinin and α-Dihydroartemisininglucuronide following Oral Administration of Artesunate in Sudanese Patients with Uncomplicated Falciparum Malaria and Healthy Volunteers. The 6th Annual Postgraduate Studies and Scientific Research Conference, Khartoum, Sudan, 18-22 Feb 2015.

This list was generated on Thu Nov 21 03:07:33 2024 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Deconstructing the immunogenecity of caspase-independent cell death to improve prostate cancer treatment
    Prostate Cancer UK
    2023 - 2026